Unither Pharmaceuticals is a global contract development and manufacturing organization (CDMO) specializing in sterile and non-sterile liquid medicines and healthcare products. With around 30 years of expertise, the company supports pharmaceutical businesses, from start-ups to international groups, across product development and commercial manufacturing. Unither is recognized as a world leader in Blow-Fill-Seal (BFS) technology for sterile single-dose products, with annual capacity exceeding five billion doses.

Its portfolio and capabilities include single- and multi-dose liquids, vials, sprays, liquid stick-packs, and tablets, serving areas such as ophthalmology, ear, nose and throat, respiratory care, and injectables. Services span formulation and analytical development, technology transfer, scale-up, clinical and commercial batch production, stability studies, ophthalmic development, and regulatory support. Unither also offers co-development partnerships and turnkey products that clients can license and market under their own brands.

The company operates production sites across Europe, the Americas, and Asia, serving markets in more than 100 countries.